What is SpaceOAR Hydrogel?
Find Out How SpaceOAR
SpaceOAR Clinical Studies
Frequently Asked Questions
WALTHAM, Mass.–(BUSINESS WIRE)–Augmenix, Inc., a privately held company developing minimally invasive hydrogel products to improve outcomes following cancer radiotherapy, today announced it secured $6 million in series E funding from existing investors. (Read More)
Consuming more tree nuts may help lower the risk of prostate cancer mortality in men.
Many of the most common misconceptions about prostate cancer are easily debunked.
SBRT treatment requires far fewer treatment sessions than tradiational radiation therapies.
in Washington, DC
in Los Angeles, California
in Banff, AB